MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹490 Cr | ₹501 Cr | ₹402 Cr | ₹321 Cr | ₹456 Cr |
What is the latest Total Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹490 Cr |
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹402 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹456 Cr |
How is Total Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹490 Cr | -2.07 | |
| Mar2025 | ₹501 Cr | 24.53 | |
| Mar2024 | ₹402 Cr | 25.18 | |
| Mar2023 | ₹321 Cr | -29.64 | |
| Mar2022 | ₹456 Cr | - | |
Compare Total Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,427.9 Cr | -1.2% | -23.7% | 95.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -1.2% |
-23.7% |
95.7% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses